These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

875 related items for PubMed ID: 9589220

  • 1. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 2. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 3. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 4. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS, Joyce JN.
    Synapse; 1992 May; 11(1):35-46. PubMed ID: 1351321
    [Abstract] [Full Text] [Related]

  • 5. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM, Bruno JP.
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [Abstract] [Full Text] [Related]

  • 6. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE, Thomas LI.
    Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912
    [Abstract] [Full Text] [Related]

  • 7. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Jan; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

  • 8. Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
    Neal BS, Joyce JN.
    Brain Res Dev Brain Res; 1991 Jun 21; 60(2):105-13. PubMed ID: 1832593
    [Abstract] [Full Text] [Related]

  • 9. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhang SP, Zhou LW, Weiss B.
    J Pharmacol Exp Ther; 1994 Dec 21; 271(3):1462-70. PubMed ID: 7996459
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Aug 21; 262(2):855-65. PubMed ID: 1354257
    [Abstract] [Full Text] [Related]

  • 11. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M.
    Synapse; 2008 Jul 21; 62(7):524-33. PubMed ID: 18435422
    [Abstract] [Full Text] [Related]

  • 12. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat.
    Simson PE, Johnson KB, Jurevics HA, Criswell HE, Napier TC, Duncan GE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Dec 21; 263(3):1454-63. PubMed ID: 1361576
    [Abstract] [Full Text] [Related]

  • 13. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ, Marshall JF.
    Synapse; 2000 Jun 01; 36(3):194-204. PubMed ID: 10819899
    [Abstract] [Full Text] [Related]

  • 14. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
    Berridge KC, Aldridge JW.
    Synapse; 2000 Sep 01; 37(3):194-204. PubMed ID: 10881041
    [Abstract] [Full Text] [Related]

  • 15. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates.
    Abrams DR, Bruno JP.
    Dev Psychobiol; 1992 Nov 01; 25(7):475-95. PubMed ID: 1459343
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 01; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 17. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 01; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 18. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H, Sato H, Ida I, Oshima A, Sakurai N, Shihara N, Horikawa Y, Mikuni M.
    Pharmacol Biochem Behav; 2007 May 01; 87(1):56-64. PubMed ID: 17499349
    [Abstract] [Full Text] [Related]

  • 19. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O, Morelli M.
    Psychopharmacology (Berl); 2002 Jul 01; 162(3):246-54. PubMed ID: 12122482
    [Abstract] [Full Text] [Related]

  • 20. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.